Dixon Hughes Goodman Wealth Advisors LLC acquired a new position in DENTSPLY SIRONA Inc. (NASDAQ: XRAY – Get Rating) in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 1,600 shares of the medical instruments supplier’s stock, valued at approximately $ 79,000.
Other hedge funds and other institutional investors have also recently bought and sold shares of the company. BlackRock Inc. boosted its holdings in DENTSPLY SIRONA by 4.2% in the fourth quarter. BlackRock Inc. now owns 17,700,553 shares of the medical instruments supplier’s stock worth $ 987,514,000 after acquiring an additional 709,095 shares in the last quarter. First Eagle Investment Management LLC lifted its holdings in DENTSPLY SIRONA by 16.5% in the fourth quarter. First Eagle Investment Management LLC now owns 7,184,012 shares of the medical instruments supplier’s stock valued at $ 400,796,000 after acquiring an additional 1,018,179 shares during the last quarter. Champlain Investment Partners LLC raised its position in DENTSPLY SIRONA by 15.6% in the fourth quarter. Champlain Investment Partners LLC now owns 5,436,245 shares of the medical instruments supplier’s stock valued at $ 303,288,000 after purchasing an additional 733,144 shares during the period. Invesco Ltd. increased its position in shares of DENTSPLY SIRONA by 12.2% during the fourth quarter. Invesco Ltd. now owns 4,452,530 shares of the medical instruments supplier’s stock worth $ 248,406,000 after acquiring an additional 482,532 shares during the period. Finally, Geode Capital Management LLC increased its holdings in DENTSPLY SIRONA by 7.2% in the fourth quarter. Geode Capital Management LLC now owns 4,352,885 shares of the medical instruments supplier’s stock valued at $ 242,283,000 after buying an additional 291,705 shares during the last quarter. 94.79% of the stock is owned by institutional investors.
In other DENTSPLY SIRONA news, Director Eric Brandt sold 6,900 shares of the firm’s stock in a transaction on Tuesday, May 3rd. The stock was sold at an average price of $ 39.71, for a total transaction of $ 273,999.00. Following the transaction, the director now directly owns 35,155 shares in the company, valued at approximately $ 1,396,005.05. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. 0.76% of the stock is currently owned by company insiders.
Shares of XRAY stock opened at $ 35.33 on Monday. The company has a debt-to-equity ratio of 0.38, a quick ratio of 1.03 and a current ratio of 1.45. DENTSPLY SIRONA Inc. has a fifty-two week low of $ 33.78 and a fifty-two week high of $ 66.98. The company has a market capitalization of $ 7.61 billion, a P / E ratio of 20.91 and a beta of 0.94. The stock has a 50 day moving average price of $ 40.34 and a two-hundred day moving average price of $ 48.43.
DENTSPLY SIRONA (NASDAQ: XRAY – Get Rating) last posted its earnings results on Tuesday, May 10th. The medical instruments supplier reported $ 0.52 earnings per share for the quarter, beating analysts’ consensus estimates of $ 0.50 by $ 0.02. DENTSPLY SIRONA had a return on equity of 11.63% and a net margin of 8.81%. The company had revenue of $ 9.67 billion for the quarter, compared to the consensus estimate of $ 982.05 million. During the same quarter in the prior year, the company earned $ 0.72 earnings per share. DENTSPLY SIRONA’s revenue was up 841.1% on a year-over-year basis. As a group, equities analysts predict that DENTSPLY SIRONA Inc. will post 2.42 earnings per share for the current year.
The business also recently disclosed a quarterly dividend, which will be paid on Friday, July 8th. Stockholders of record on Friday, June 24th will be paid a $ 0.125 dividend. This represents a $ 0.50 annualized dividend and a dividend yield of 1.42%. The ex-dividend date of this dividend is Thursday, June 23rd. DENTSPLY SIRONA’s payout ratio is 29.59%.
XRAY has been the subject of several recent analyst reports. UBS Group upgraded shares of DENTSPLY SIRONA from a “neutral” rating to a “buy” rating and reduced their price objective for the company from $ 58.00 to $ 47.00 in a research note on Wednesday, June 1st. Bank of America lowered shares of DENTSPLY SIRONA from a “buy” rating to a “neutral” rating and decreased their price objective for the stock from $ 66.00 to $ 49.00 in a report on Tuesday, April 19th. Morgan Stanley dropped their price target on DENTSPLY SIRONA from $ 62.00 to $ 52.00 and set an “overweight” rating on the stock in a research report on Wednesday, April 20th. HC Wainwright decreased their price target on DENTSPLY SIRONA from $ 58.00 to $ 48.00 and set a “hold” rating for the company in a research note on Friday, April 22nd. Finally, Barrington Research decreased their target price on DENTSPLY SIRONA from $ 53.00 to $ 51.00 in a research report on Wednesday, May 11th. Six investment analysts have rated the stock with a hold rating and five have issued a buy rating to the company. Based on data from MarketBeat, the stock has an average rating of “Hold” and a consensus price target of $ 50.56.
DENTSPLY SIRONA Company Profile: (Get Rating)
DENTSPLY SIRONA Inc designs, develops, manufactures, distributes, and sells various dental products and technologies for professional dental market worldwide. It offers dental equipment, including treatment centers, imaging equipment, motorized dental handpieces, and other instruments; imaging equipment; treatment centers comprising basic dentist chairs, sophisticated chair-based units with integrated diagnostic, hygiene and ergonomic functionalities, and specialist centers; and lab equipment, such as amalgamators, mixing machines, and porcelain furnaces.
Further Reading:
Receive News & Ratings for DENTSPLY SIRONA Daily: – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for DENTSPLY SIRONA and related companies with MarketBeat.com’s FREE daily email newsletter.
.